Accesso libero

The Acute Effects of Different Spironolactone Doses on Oxidative Stress in Streptozotocin-Induced Diabetic Rats

Stefan Simovic

Stefan Simovic

  • University of Kragujevac, Faculty of Medical Sciences, Department of Internal MedicineSerbia
  • Clinic for Cardiology, Clinical Center KragujevacSerbia
Cerca questo autore su
Sciendo|Google Scholar
Simovic, Stefan
, 
Aleksandra Vranic

Aleksandra Vranic

University of Kragujevac, Faculty of Medical Sciences, Department of PharmacySerbia
Cerca questo autore su
Sciendo|Google Scholar
Vranic, Aleksandra
, 
Petar Ristic

Petar Ristic

Clinic of Endocrinology, Military Medical AcademyBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Ristic, Petar
, 
Jovana Jeremic

Jovana Jeremic

University of Kragujevac, Faculty of Medical Sciences, Department of PharmacySerbia
Cerca questo autore su
Sciendo|Google Scholar
Jeremic, Jovana
, 
Ivan Srejovic

Ivan Srejovic

University of Kragujevac, Faculty of Medical Sciences, Department of PhysiologySerbia
Cerca questo autore su
Sciendo|Google Scholar
Srejovic, Ivan
, 
Jasna Petrovic

Jasna Petrovic

General Hospital “Valjevo”Valjevo, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Petrovic, Jasna
, 
Vladimir Jakovljevic

Vladimir Jakovljevic

  • University of Kragujevac, Faculty of Medical Sciences, Department of PhysiologySerbia
  • Department of Human PathologyMoscow, Russia
Cerca questo autore su
Sciendo|Google Scholar
Jakovljevic, Vladimir
, 
Stefani Bolevich

Stefani Bolevich

Department of PathophysiologyMoscow, Russia
Cerca questo autore su
Sciendo|Google Scholar
Bolevich, Stefani
, 
Sergey Bolevich

Sergey Bolevich

Department of Human PathologyMoscow, Russia
Cerca questo autore su
Sciendo|Google Scholar
Bolevich, Sergey
 e 
Vladimir Zivkovic

Vladimir Zivkovic

University of Kragujevac, Faculty of Medical Sciences, Department of PhysiologySerbia
Cerca questo autore su
Sciendo|Google Scholar
Zivkovic, Vladimir
  
26 mag 2021
The Acute Effects of Different Spironolactone Doses on Oxidative Stress in Streptozotocin-Induced Diabetic Rats's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Original Scientific Article
Pubblicato online: 26 mag 2021
Pagine: 103 - 112
Ricevuto: 16 mar 2021
Accettato: 22 mar 2021
DOI: https://doi.org/10.2478/sjecr-2021-0025
Parole chiave
© 2024 Stefan Simovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1.

Parameters of oxidative stress in healthy rats perfused with 0.1 μM of spironolactone compared with diabetic rats perfused with 0.1 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2-) (c) Superoxide anion radical (O2-) (d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.
Parameters of oxidative stress in healthy rats perfused with 0.1 μM of spironolactone compared with diabetic rats perfused with 0.1 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2-) (c) Superoxide anion radical (O2-) (d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.

Figure 2.

Parameters of oxidative stress in healthy rats perfused with 3 μM of spironolactone compared with diabetic rats perfused with 3 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2-) (c) Superoxide anion radical (O2-) (d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.
Parameters of oxidative stress in healthy rats perfused with 3 μM of spironolactone compared with diabetic rats perfused with 3 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2-) (c) Superoxide anion radical (O2-) (d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.

Figure 3.

Parameters of oxidative stress in healthy rats perfused with 0.1 μM of spironolactone compared with healthy rats perfused with 3 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2−) (c) Superoxide anion radical (O2−) (d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.
Parameters of oxidative stress in healthy rats perfused with 0.1 μM of spironolactone compared with healthy rats perfused with 3 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2−) (c) Superoxide anion radical (O2−) (d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.

Figure 4.

Parameters of oxidative stress in diabetic rats perfused with 0.1 μM of spironolactone compared with diabetic rats perfused with 3 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2−) (c) Superoxide anion radical (O2−)(d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.
Parameters of oxidative stress in diabetic rats perfused with 0.1 μM of spironolactone compared with diabetic rats perfused with 3 μM of spironolactone. (a) Hydrogen peroxide (H2O2) (b) Nitrites (NO2−) (c) Superoxide anion radical (O2−)(d) Index of lipid peroxidation (measured as TBARS). Data is presented as mean ± SD. CPP, coronary perfusion pressure.

Percentage of reduction or increase in the each of the parameters of oxidative stress in healthy and diabetic rats treated with different spironolactone doses_

40 cmH2O 60 cmH2O 80 cmH2O 100 cmH2O 120 cmH2O
H2O2 0.1 μM spironolactone healthy vs. control +20.49 +1.34 +1.30 −7.57 0.00
3 μM spironolactone healthy vs. control +11.12 −3.88 +0.79 −12.62 +9.40
0.1 μM spironolactone diabetic vs. diabetic −0.12 −11.62 −0.28 +8.73 −8.08
3 μM spironolactone diabetic vs. diabetic −12.22 −33.73 −37.84 −20.12 −43.83
NO2− 0.1 μM spironolactone healthy vs. control +13.69 −10.83 −20.12 −19.92 −31.26
3 μM spironolactone healthy vs. control −2.03 −13.64 −0.36 −4.74 +0.90
0.1 μM spironolactone diabetic vs. diabetic +4.12 −6.74 −4.91 +1.26 −0.98
3 μM spironolactone diabetic vs. diabetic −3.46 −11.98 −14.09 −9.54 −11.25
O2− 0.1 μM spironolactone healthy vs. control +5.55 −53.58 −14.75 +41.34 −16.96
3 μM spironolactone healthy vs. control +16.83 −6.04 −16.97 −20.30 −11.92
0.1 μM spironolactone diabetic vs. diabetic −21.85 −3.80 +32.66 +19.34 +67.14
3 μM spironolactone diabetic vs. diabetic +6.31 −32.84 −25.24 −15.17 −46.94
TBARS 0.1 μM spironolactone healthy vs. control +7.85 +1.32 −6.91 −10.89 −9.93
3 μM spironolactone healthy vs. control +7.64 +5.60 +27.74 +28.50 +31.63
0.1 μM spironolactone diabetic vs. diabetic +5.25 −6.02 −7.06 +0.60 −3.87
3 μM spironolactone diabetic vs. diabetic −13.61 −48.17 −49.53 −46.99 −47.15
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina clinica, altro
Feed RSS della rivista